Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IB & II study of Ribociclib with Trastuzumab plus Letrozole in HR+, HER2+ Advanced Breast Cancer
KCT0003311Phase 2Active, not recruiting
- Sponsor
- Celltrion
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in breast cancer, sponsored by Celltrion. Started Jun 2019; status: active, not recruiting.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0003311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003311.